Newbridge Financial Services Group’s Editas Medicine EDIT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-300	Closed	-$1.04K	–	1278
2025 Q3	$1.04K	Hold	300	–	–	﹤0.01%	1183
2025 Q2	$660	Hold	300	–	–	﹤0.01%	1229
2025 Q1	$348	Hold	300	–	–	﹤0.01%	983
2024 Q4	$381	Hold	300	–	–	﹤0.01%	1066
2024 Q3	$1.02K	Hold	300	–	–	﹤0.01%	595
2024 Q2	$1.4K	Sell	300 -200	-40%	-$1.13K	﹤0.01%	978
2024 Q1	$3.71K	Buy	500 +200	+67%	+$1.66K	﹤0.01%	925
2023 Q4	$3.04K	Sell	300 -3,000	-91%	-$26.3K	﹤0.01%	925
2023 Q3	$25.7K	Sell	3,300 -821	-20%	-$7.04K	0.01%	586
2023 Q2	$33.9K	Hold	4,121	–	–	0.02%	553
2023 Q1	$29.9K	Sell	4,121 -1,491	-27%	-$13.3K	0.02%	593
2022 Q4	$49.8K	Sell	5,612 -170	-3%	-$1.87K	0.03%	464
2022 Q3	$71K	Buy	5,782 +5,470	+1,753%	+$85.2K	0.04%	365
2022 Q2	$4K	Sell	312 -23	-7%	-$308	﹤0.01%	1047
2022 Q1	$6K	Sell	335 -185	-36%	-$3.44K	﹤0.01%	1054
2021 Q4	$14K	Buy	520 +160	+44%	+$5.51K	0.01%	832
2021 Q3	$15K	Sell	360 -2,425	-87%	-$133K	0.01%	745
2021 Q2	$158K	Buy	2,785 +2,007	+258%	+$74.1K	0.1%	210
2021 Q1	$33K	Sell	778 -185	-19%	-$10.5K	0.02%	526
2020 Q4	$68K	Buy	963 +327	+51%	+$13.4K	0.06%	268
2020 Q3	$18K	Buy	+636	New	+$20.7K	0.02%	527